Alpha-synuclein stepwise aggregation reveals features of an early onset mutation in Parkinson’s disease

被引:0
|
作者
Guilherme A. P. de Oliveira
Jerson L. Silva
机构
[1] Federal University of Rio de Janeiro,Institute of Medical Biochemistry Leopoldo de Meis, National Institute of Science and Technology for Structural Biology and Bioimaging, National Center of Nuclear Magnetic Resonance Jiri Jonas
[2] University of Virginia,Department of Biochemistry and Molecular Genetics
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Amyloid formation is a process involving interconverting protein species and results in toxic oligomers and fibrils. Aggregated alpha-synuclein (αS) participates in neurodegenerative maladies, but a closer understanding of the early αS polymerization stages and polymorphism of heritable αS variants is sparse still. Here, we distinguished αS oligomer and protofibril interconversions in Thioflavin T polymerization reactions. The results support a hypothesis reconciling the nucleation-polymerization and nucleation-conversion-polymerization models to explain the dissimilar behaviors of wild-type and the A53T mutant. Cryo-electron microscopy with a direct detector shows the polymorphic nature of αS fibrils formed by heritable A30P, E46K, and A53T point mutations. By showing that A53T rapidly nucleates competent species, continuously elongates fibrils in the presence of increasing amounts of seeds, and overcomes wild-type surface requirements for growth, our findings place A53T with features that may explain the early onset of familial Parkinson’s disease cases bearing this mutation.
引用
收藏
相关论文
共 50 条
  • [1] Alpha-synuclein stepwise aggregation reveals features of an early onset mutation in Parkinson's disease
    de Oliveira, Guilherme A. P.
    Silva, Jerson L.
    COMMUNICATIONS BIOLOGY, 2019, 2 (1)
  • [2] Alpha-Synuclein Aggregation in Parkinson's Disease
    Srinivasan, E.
    Chandrasekhar, G.
    Chandrasekar, P.
    Anbarasu, K.
    Vickram, A. S.
    Karunakaran, Rohini
    Rajasekaran, R.
    Srikumar, P. S.
    FRONTIERS IN MEDICINE, 2021, 8
  • [3] Lipids and alpha-synuclein aggregation in Parkinson's disease
    Broersen, K.
    Davletov, B.
    MOVEMENT DISORDERS, 2007, 22 (12) : VI - VI
  • [4] Glycated Alpha-Synuclein and it's Emerging Role in Early Onset of Parkinson's Disease
    Chatterjee, S.
    Thakkar, H.
    Khairnar, A.
    Shah, R.
    MOVEMENT DISORDERS, 2023, 38 : S639 - S639
  • [5] Triggers of alpha-synuclein aggregation and inhibition in Parkinson's disease
    Baum, Jean
    Janowska, Maria
    Olson, Michael
    Atieh, Tamr
    Nunes, Ana Monica
    Moriarty, Gina
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [6] Immunotherapy in Parkinson's Disease: Micromanaging Alpha-Synuclein Aggregation
    George, Sonia
    Brundin, Patrik
    JOURNAL OF PARKINSONS DISEASE, 2015, 5 (03) : 413 - 424
  • [7] Targeting alpha-Synuclein Aggregation for the Treatment of Parkinson's Disease
    Tsika, E.
    Gabellieri, E.
    Davranche, A.
    Boudou, C.
    Ravache, M.
    Grasso, L.
    Nampally, S.
    Haddouk, H.
    Wettstein, J.
    Pfeifer, A.
    Muhs, A.
    MOVEMENT DISORDERS, 2017, 32
  • [8] A Novel Alpha-Synuclein Missense Mutation in Parkinson's Disease
    Proukakis, Christos
    Katsianou, Maria
    Hummel, Angelika
    Brier, Timothy
    Houlden, Henry
    Cooper, Jonathan Mark
    Schapira, Anthony H.
    ANNALS OF NEUROLOGY, 2012, 72 : S130 - S130
  • [9] Rapid FRET Assay for the Early Detection of Alpha-Synuclein Aggregation in Parkinson's Disease
    Yu, Hang
    Feng, Rui
    Chen, Fenglin
    Wu, Zuodong
    Li, Dehai
    Qiu, Xue
    ACS CHEMICAL NEUROSCIENCE, 2024, 15 (07): : 1378 - 1387
  • [10] Alpha-synuclein and Parkinson's disease
    Golbe, LI
    MOVEMENT DISORDERS, 1999, 14 (01) : 6 - 9